Stryker Appoints Spencer Stiles as New COO

Stryker ( (SYK) ) has shared an update.

On December 4, 2025, Stryker announced the appointment of Spencer Stiles as President and Chief Operating Officer, effective January 1, 2026. Stiles, a 27-year veteran of the company, will lead Stryker’s global businesses, strategy, and mergers & acquisitions. This leadership change aims to sustain high growth and leverage the company’s portfolio. Dylan Crotty will succeed Stiles as Group President, Orthopaedics, also effective January 1, 2026. Crotty, who has been with Stryker for 27 years, is recognized for his strong operational leadership and collaboration.

The most recent analyst rating on (SYK) stock is a Buy with a $450.00 price target. To see the full list of analyst forecasts on Stryker stock, see the SYK Stock Forecast page.

Spark’s Take on SYK Stock

According to Spark, TipRanks’ AI Analyst, SYK is a Outperform.

Stryker’s overall stock score is driven by strong financial performance and positive earnings call outcomes, reflecting robust growth and strategic execution. However, technical analysis indicates bearish trends, and the high P/E ratio suggests a premium valuation. Despite these challenges, the company’s solid fundamentals and raised guidance support a positive outlook.

To see Spark’s full report on SYK stock, click here.

More about Stryker

Stryker is a global leader in medical technologies, offering innovative products and services in MedSurg, Neurotechnology, and Orthopaedics to improve patient and healthcare outcomes. The company impacts more than 150 million patients annually alongside its customers worldwide.

Average Trading Volume: 1,551,180

Technical Sentiment Signal: Buy

Current Market Cap: $140.2B

For a thorough assessment of SYK stock, go to TipRanks’ Stock Analysis page.